6. More Risk Factors
Overweight (Abdominal)
Over 45 years old
Sedentary Lifestyle
Non-White Race
Family History of DB
Family History of High
BP
History of High BP (self)
High Cholesterol
History of Gestational
Goals:
DB
Women < 35 Delivered a baby > 9 lbs.
Men < 40
7. What Happens in Type 2 DM
Pancreas can’t make Stomach empties 50%
enough insulin faster than normal
Type 2
Diabetes
Liver puts too Muscle cells and
much sugar other tissues are
into the blood resistant to insulin
13. Criteria ATP III WHO AACE IDF
(AHA/
NHLB)
M > 102 cm BMI > 30 or BMI > 25 *M > 94 cm
W > 88 cm W : H Ratio *W > 80 cm
Abdominal M > 0.9 or BMI > 30
Obesity W> 0.85 + 2 others
Triglycerides > 150 mg/dl same same Same or on
meds
HDL M < 40 M < 35 M < 40 M < 40 (or on
W < 50 W < 39 W < 50 W < 50 meds)
Blood Pressure > 130/85 > 140/90 > 130/85 > 130/85 or on
or on meds or on meds meds
Fasting > 100 mg/dl T2 DM, IFG or Btw. 110 – > 100 or T2DM
Glucose or on meds IGT * 126 mg/dl
+2 others
Other Urinary Albumin 2 hr PP > 140;
Excretion Rate > PCOS; family
20 or alb:creatine hx; other
ratio > 30
14. 90% of T2DM: IR and MS
Adapted from International Diabetes Center (IDC), Minneapolis, Minnesota.
18. Diabetes in the United States
Estimated prevalence: Nearly 24 million
Nearly 8% of the U.S. population
Almost 25% of persons over age 60
90 - 95% have type 2
25% do not know they have it!
57 million have pre-diabetes
24% have Metabolic Syndrome
Projected 44-68% increase in diabetes by 2015
8% per year
19. Diabetes in the United States
NOT an Equal Opportunity Disease!
Among those diagnosed…
16.5% of Native Americans/Alaskan Natives
11.8% of Black Americans
10.4% of Latinos*
12.6% of Puerto Ricans
11.9% of Mexicans
8.2% of Cubans
7.5% Asian Americans
6.6% Caucasians
Lifetime DM risk (born after 2000)
33% men; 39% women; 50% Hispanic women
21. Obesity and Diabetes
1:3 Americans are obese
1:5 Americans are morbidly obese
80% of all Type 2 diabetics are
overweight
Obesity in children has
doubled in 20 years
Type 2 diabetes in
children has tripled
in the last 5 years
22. Children and Type 2
Diabetes
Mean age: 12-14
years old
Girls > Boys
Overweight
94% are in minority
groups
74-100% have a
strong family history
23. Overweight Kids Become
Overweight Adults
50% of overweight
children become
overweight adults
26-41% overweight
preschool children
will become
overweight adults
24. What about our children?
In a study done involving 111 children,
57% were obese, 12% were super-
obese
In families of children who were obese
~ the caregiver thought the child’s
weight was a problem in only 44% of
the cases
Young-Hayman, D. et al Obesity Research 2000:8:241-8
25. Saturday Morning
Influence
61% of all
commercials
are for FOOD
90% are for sugared
cereals, candy bars,
fast food,
and chips
26. INDIANA
Diabetes Obesity
State ranking for State ranking for
prevalence (2008) prevalence (2008)
Adults: Ranked 38th Ranked 31st
Diabetes in Indiana is Adults in Indiana
above the national (2006)
average: 27.5 % obese
National Average: 35% overweight
8.0%
Indiana Average:
8.5%
28. Costs of Diabetes in the
U.S.
$174 billion each year
$116 billion in direct
medical costs
$58 billion in indirect
costs
Missed work
Lost productivity
1 in 10 healthcare
dollars spend on
diabetes/complications
Human costs
leading cause of
7th
death
30. Health Impact of
Diabetes in the United
States
6th leading cause of death
Leading cause of 73% of adults have
kidney failure HTN and/or take meds
Diabetes
Leading cause Heart disease is the
of adult blindness leading cause of
death
Neuropathy in 60-70% of patients contributes
to high incidence of lower-limb amputation
National Diabetes Fact Sheet, United States, November 2003.
Available at http:;;www.cdc.gov/diabetes/pubs/factsheet.htm.
31. Diabetes Increases Death Rate
0.25
0.2
Event rate
Diabetes/CVD
0.15 Diabetes/No CVD
No Diabetes/CVD
0.1
No Diabetes/No CVD
0.05
3 6 9 12 15 18 21 24 Months
0
Organization to Assess Strategies for Ischemic Syndromes
Malmberg K, et al. Circulation. 2000;102:1014-1019. www.hypertensiononline.org
32. Causes of Death in Diabetes
50
40
40
30
20 15
13 13
10
10 4 5
s h ae d f o t necr e P
0
er
ic e s r
en ia/
as rt
te ce
za
th
m s
se a
e
he sea be an ke
flu n
di he
lo
in mo
c ia
ro
C
Is di
er
Al
D
St
eu
t
th
ar
Pn
O
he
Geiss LS, et al. In: Diabetes in America.
t
National Institutes of Health;1995. www.hypertensiononline.org
33. Diabetes Management
Receives
a Failing Report Card…
Indicator of Diabetes Percent of Patients
Mgmt at Goal
A1C 37%
NHANES III
1988-1994 7.8%
NHANES
1999-2000 8.1%
LDL Cholesterol 23%
Systolic BP 41%
Beaton, S.et al. Diabetes Care 27: 694-698, 2004
34. Now the Good News:
Diabetes Can Be
Prevented
Diabetes Prevention Program
N= 3,234 people with IGT
Ages 25-85 (mean 51)
Average BMI 34
45% minorities
Goals
Achieve/maintain weight loss of 7%
Maintain moderate physical activity at
least 150 minutes/week
35.
36. Preventing Diabetes
--or Living Healthy with It!
Lifestyle Changes
Healthy Eating
Regular Exercise
Healthy Weight
Weight Loss (7% of weight)
Medications
Weight Loss Surgery
39. Plate Method
Fill ½ of the plate with non-starchy vegetables
Finish with
Don’t forget
a fruit
the dairy!
Choose a carb
serving Add a serving
of a protein food
40. The Supersizing P henomenon
Portion Control - I t Does
M t er !
at
29G
26G
700 77G
610
22G 68G
600
500 10G Fat 57G 450
Calories
400 320
26 Grams Carbs
300
210
200
100
0
1960 1978 1995 1999
Year
41. Activity and Exercise
30 minutes of moderate activity
on most days of the week
This does
NOT
Count!
44. Height Normal Overweight Obese Extreme
Obesity
BMI=<25 BMI=25-29 BMI=30-39 BMI=>40
5 ft 0 in Up to 127 Up to 152 Up to 203 Over 203
5 ft 1 in Up to 131 Up to 157 Up to 210 Over 210
5 ft 2 in Up to 135 Up to 163 Up to 217 Over 217
5 ft 3 in Up to 140 Up to 168 Up to 224 Over 224
5 ft 4 in Up to 144 Up to 173 Up to 231 Over 231
5 ft 5 in Up to 149 Up to 179 Up to 239 Over 239
5 ft 6 in Up to 154 Up to 185 Up to 246 Over 246
5 ft 7 in Up to 158 Up to 190 Up to 254 Over 254
5 ft 8 in Up to 163 Up to 196 Up to 261 Over 261
5 ft 9 in Up to 168 Up to 202 Up to 269 Over 269
5 ft 10 in Up to 173 Up to 208 Up to 277 Over 277
5 ft 11 in Up to 178 Up to 214 Up to 285 Over 285
6 ft 0 in Up to 183 Up to 220 Up to 293 Over 293
6 ft 1 in Up to 188 Up to 226 Up to 301 Over 301
6 ft 2 in Up to 193 Up to 232 Up to 310 Over 310
6 ft 3 in Up to 199 Up to 239 Up to 318 Over 318
6 ft 4 in Up to 204 Up to 245 Up to 327 Over 327
45. Medications
Prevention of Diabetes
Metformin (Glucophage)
Controlling Diabetes
Pills, Insulin, and other Injectables
Weight Loss
Orlistat (Alli- OTC)
Meridia
Others
46. “Diabetes Surgery”
Lab-Band (1 year)
64% of patients showed resolution
26% of patients showed improvement
Roux-en-Y Gastric Bypass
76.8% of patients showed resolution
- other studies showed 83% - 98%
48. ”The distance is nothing; it is only the first step that is difficult.”
Hinweis der Redaktion
NGT = Normal Glucose Tolerance IFG/IGT = Impaired Fasting Glucose/Impaired Glucose Tolerance IR = Insulin Resistance MS = Metabolic Syndrome -Cell failure occurs following an adaptative phase of hypersecretion in response to the development of insulin resistance.
Prevalence of Diabetes The Centers for Disease Control and Prevention (CDC) has compiled data on diabetes in the United States obtained from several surveys, including the National Health Interview Survey (NHIS), the Third National Health and Nutrition Examination Survey (NHANES III), the National Hospital Discharge Survey, and surveys conducted through the Behavioral Risk Factor Surveillance System (BRFSS). Based on data from these sources, the CDC estimates that 17 million people, or 6.2% of the population, had diabetes in 2000. A third of these cases were undiagnosed. Almost 9% of people 20 years old and 20.1% of people 65 years old had diabetes. The estimated worldwide prevalence of diabetes in 1997, derived from World Health Organization (WHO) data, was 124 million people, with the majority (97%) having type 2 diabetes. According to the same projections, the number of people with diabetes is expected to increase to 221 million in 2010. Other less conservative projections by King et al used WHO data combined with demographic estimates and projections issued by the United Nations to place the number of people worldwide with diabetes at 135.3 million in 1995 and 300 million in 2025. References: The Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2000. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2002. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14:S7-S85. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-1431.
Prevalence of Diabetes The Centers for Disease Control and Prevention (CDC) has compiled data on diabetes in the United States obtained from several surveys, including the National Health Interview Survey (NHIS), the Third National Health and Nutrition Examination Survey (NHANES III), the National Hospital Discharge Survey, and surveys conducted through the Behavioral Risk Factor Surveillance System (BRFSS). Based on data from these sources, the CDC estimates that 17 million people, or 6.2% of the population, had diabetes in 2000. A third of these cases were undiagnosed. Almost 9% of people 20 years old and 20.1% of people 65 years old had diabetes. The estimated worldwide prevalence of diabetes in 1997, derived from World Health Organization (WHO) data, was 124 million people, with the majority (97%) having type 2 diabetes. According to the same projections, the number of people with diabetes is expected to increase to 221 million in 2010. Other less conservative projections by King et al used WHO data combined with demographic estimates and projections issued by the United Nations to place the number of people worldwide with diabetes at 135.3 million in 1995 and 300 million in 2025. References: The Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2000. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2002. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14:S7-S85. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-1431.
OASIS Study Mortality by Diabetes and CVD Status Data from the Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry were analyzed to determine the 2-year prognosis of diabetic and nondiabetic patients who were hospitalized with unstable angina or non–Q-wave myocardial infarction. Outcomes that were studied included total mortality, cardiovascular death, new myocardial infarction, stroke, and new congestive heart failure. A total of 1,718 of the 8,013 registry patients had diabetes (21%). Because patients with diabetes were more likely to have established cardiovascular disease (CVD) at baseline, stratified analyses were performed according to prior CVD and diabetes status. The 2-year mortality rate for diabetic patients was 20.3% for those with prior CVD compared to 13.0% for those without prior CVD. For patients without diabetes, the rate was 12.9% for those with prior CVD compared to 6.9% for those without prior CVD. The P value was <0.001 for a comparison of patients with and without diabetes within the 2 CVD strata. Diabetic patients without prior CVD had the same event rates for total mortality, and all other outcomes, as nondiabetic patients with previous CVD. The CV death rate for diabetic patients with prior CVD was 16.6% compared to 9.3% for those without prior CVD. For patients without diabetes, the rate was 10.5% for those with prior CVD compared to 5.1% for those without prior CVD. The P value was also <0.001 for a comparison of patients with and without diabetes within the 2 CVD strata. Reference: Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, Piegas L, Calvin J, Keltai M, Budaj A. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000;102(9):1014-1019.
Causes of Death in People With Diabetes Based on data collected from 4 cohort studies in the US conducted between 1965 and 1988, it was determined that the leading causes of death listed on the death certificates of persons with diabetes were diseases of the heart (55%), diabetes (13%), malignant neoplasms (13%), and cerebrovascular disease (10%). Despite variation in the way underlying cause of death was classified, the proportion of persons dying from these causes was similar across the 4 studies. Geiss et al also found that the risk of heart disease mortality and ischemic heart disease mortality was 2 to 4 times higher in persons with diabetes than in persons without diabetes. For persons with diabetes, the excess risk of dying from heart disease and ischemic heart disease was higher than the excess risk of mortality for all other causes combined. While the studies may not have distinguished between insulin-dependent diabetes and non-insulin-dependent diabetes (NIDDM), it was assumed that the diabetes deaths were NIDDM deaths because of the older age of the populations and the increased prevalence of NIDDM in older age groups. Reference: Geiss LS, Herman WH, Smith PJ. Mortality in Non-Insulin-Dependent Diabetes. In: National Diabetes Data Group, eds. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995.
Portion Size Does Matter: Portion control can make a great difference in your blood sugars. Let’s look at what has happened to an order of french fries from 1960 to 1999. In addition: The Average Dinner Plate Size in 1956 was 8”. The Average Dinner Plate Size in 2003 is 10.5”. The Large Drink at McDonald’s in 1961 was 12 oz. The Large Drink at McDonald’s in 2003 is 44 oz. The Average Restaurant Spaghetti Serving in 1969 was 11 oz. The Average Restaurant Spaghetti Serving in 2003 is 21 oz. In 1961 bread, chips or other pre-meal foods were either charged for or given free 13% of the time. In 2003 bread, chips or other pre-meal foods are given free 66% of the time.
Review Bullet Points Emphasize that there are many ways to increase physical activity It is important to pick an activity that is enjoyable, otherwise it will be hard to stick with it. Brisk walking is one of the easiest activities to start with. It requires no special equipment, and can be done indoors (shopping malls) and outdoors. Explain role/benefits of increasing physical activity. Ask the participants to give some benefits of increasing their physical activity. Let them have time to answer. If there is no response then give a couple of examples. Improves circulation and respiratory system Lowers blood pressure Increases sensitivity to insulin action Promotes gradual weight loss Helps maintain desired weight Improves energy level (you feel better) Improves your sleeping Improves good cholesterol while lowering bad cholesterol Patients should talk with their physicians to see if there are any health problems that would limit which physical activities they can participate in. Notes ____________________________________________________________________________________________________________________________________________________________________________________________________
Prandin is a registered trademark of Novo Nordisk A/S. Starlix is a registered trademark of Novartis Pharmaceuticals Corporation. Glucophage is a registered trademark of Merck Sante S.A.S. and licensed to Bristol-Myers Squibb Company. Precose is a registered trademark of Bayer Pharmaceuticals Corporation. Glycet is a registered trademark of Bayer Pharmaceuticals Corporation, to Pharmacia-Upjohn. Avandia is a registered trademark of GlaxoSmithKline. Actos is a registered trademark of Takeda Chemical Industries, Ltd.